Dievo Surgery Center
Dievo Surgery Center
Ukraine, Kyiv
Abu Shamsiya Rami Nuamanovych
27 years of experience
Clinic is certified :
Immunotherapy in Kyiv typically costs from $3,200 to $6,700. The total price depends on the drug brand, the number of cycles, and the specific cancer type. Patients save around 82% compared to the US, where this procedure costs $28,500 on average. Most clinics include physician consultations, medication administration, and diagnostic monitoring in their pricing.
Bookimed Expert Insight: Kyiv centers concentrate the highest volume of cancer cases in Ukraine. This lets clinics offer treatments according to NCCN international protocols at lower prices than European peers. Spizhenko Clinic and Dobrobut Medical Network provide full-cycle care with ISO and NCCN standards. These centers serve thousands of international patients, combining precision medicine with affordable diagnostics.
| Kyiv | Turkey | Austria | |
| Immunotherapy | ≈ $3,200 | from $3,000 | ≈ $9,000 |
| Sarcoma Immunotherapy | ≈ $3,800 | from $8,900 | ≈ $18,000 |
| Immunotherapy for prostate cancer | ≈ $3,100 | from $8,000 | ≈ $30,000 |
| Immunotherapy for lung cancer | ≈ $4,800 | from $8,000 | ≈ $30,000 |
| Immunotherapy for kidney cancer | ≈ $4,200 | from $8,000 | ≈ $28,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy journey.
Day 1
Day 2
Day 3
Day 4
Day 5 to Day 7
Week 2
Week 3
Week 4
Please note that each patient"s case is unique and the above schedule can change depending on the patient"s health condition and response to the treatment.
Dr. Abu Shamsiya Rami Nuamanovych is a surgical oncologist and gastrointestinal specialist at Dievo Surgery Center. He serves as a consultant for the World Health Organization regarding laparoscopic procedures. Dr. Nuamanovych has performed thousands of surgeries, including bariatric and complex cancer operations. He is the President of the Association of Arab Doctors of Ukraine.
Written by Kateryna Zamkovska
Kyiv oncology centers evaluate immunotherapy candidates. The evaluation includes molecular tumor profiling, multidisciplinary tumor board reviews, and biomarker testing. Specialists follow NCCN and ESMO protocols to assess PD-L1 expression and MSI/MMR status. This ensures patients have the specific biological markers needed for checkpoint inhibitors to be effective.
Bookimed Expert Insight: Kyiv centers often serve as sites for international clinical trials. These trials are for lung cancer and melanoma. For example, Universal Clinic Oberig and Spizhenko Clinic are involved. So patients can access the same standardized evaluation protocols used in Western Europe. However, wait times for advanced molecular diagnostics are often shorter.
Patient Consensus: Patients emphasize bringing original biopsy blocks and slides to Kyiv to avoid diagnostic delays. They recommend checking the registration status of specific drugs in Ukraine. It is best to do this at the initial consultation, especially for drugs like pembrolizumab.
Patients can receive immunotherapy in Kyiv at specialized oncology centers. Spizhenko Clinic and Universal Clinic Oberig are two examples. These centers provide cancer treatments including checkpoint inhibitors and targeted therapies. Care follows international protocols such as NCCN and ESMO to meet global safety standards.
Bookimed Expert Insight: Patients may seek immunotherapy directly. Still, the most successful outcomes in Kyiv often start with clinical trial eligibility. Clinics like Spizhenko and Oberig frequently host international trials. Choosing a trial-active center can provide access to the latest therapies. Patients can get these therapies before they become standard commercial treatments.
Patient Consensus: Patients emphasize that immunotherapy is not for everyone. Success depends heavily on biomarker testing, specifically MSI and PD-L1 status. Both markers must be confirmed before starting any infusion regimen.
Oncology centers in Kyiv treat advanced melanoma, non-small cell lung cancer, and renal cell carcinoma. They commonly use immunotherapy. Leading facilities like Spizhenko Clinic and Dobrobut Medical Network follow NCCN and ESMO protocols. They use immune checkpoint inhibitors and monoclonal antibodies for metastatic or inoperable cases.
Bookimed Expert Insight: Clinics often offer standard protocols. However, Universal Clinic Oberig stands out by participating in international clinical trials for lung cancer. Patients there can access emerging therapies not yet widely available. The clinic also uses HEPA 14 filtration. This makes treatment safer for immunocompromised patients during intensive treatment cycles.
Patient Consensus: Patients emphasize that immunotherapy can lead to major tumor regression. However, side effects like thyroid dysfunction or fatigue often appear months into treatment. Patients recommend checking that emergency support is available for possible immune-related complications before starting infusions.